Investigation of a correlation between monoamine oxidase B and catechol-O-methyltransferase activity in human blood cells

European Journal of Pharmaceutical Sciences

Volumn 12, Issue 2, 2000, Pages 159-163

  Dingemanse, Jasper ^a   Zürcher, Gerhard ^b   Kettler, Rolf ^c  

^a Jacor Research   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Swiss Pharma Contract Ltd   (Switzerland)

Author keywords

COMT activity; Correlation; Erythrocytes; MAO B activity; Platelets

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATECHOL METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENE CONTROL; GENE LOCUS; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; THROMBOCYTE;

ADOLESCENT; ADULT; AGED; AGING; BLOOD PLATELETS; CATECHOL O-METHYLTRANSFERASE; ERYTHROCYTES; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MONOAMINE OXIDASE;

EID: 0033692929     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00151-2     Document Type: Article

References (34)

1. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327
2. Human liver catechol-O-methyltransferase pharmacogenetics
3. Treatment of Parkinson's disease
4. Platelets as a model for neurones?
5. Catechol-O-methyltransferase inhibitors: clinical potential in the treatment of Parkinson's disease
6. Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans
7. Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa
8. Multiple-dose clinical pharmacology of the catechol-O-methyltransferase inhibitor tolcapone in elderly subjects
9. The inheritance of human erythrocyte catechol-O-methyltransferase activity
10. Dopamine is a monoamine oxidase B substrate in man
11. Catechol-O-methyltransferase: pharmacological aspects and physiological role
12. Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution
13. Monoamine oxidase A and B inhibitors
14. Some observations upon a new inhibitor of monoamine oxidase in brain tissue
15. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance
16. Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system
17. Catecholamine metabolism: basic aspects and clinical significance
18. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
19. Pharmacokinetics of levodopa
20. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression
21. Catechol-O-methyltransferase activity: a determinant of levodopa response
22. (-)-Deprenyl treatment of patients with Parkinson's disease does not affect erythrocyte catechol-O-methyltransferase activity
23. Biphasic and region-specific MAO-B response to aging in normal human brain
24. Monoamine oxidase and catechol-O-methyltransferase inhibitors
25. Major gene model for the inheritance of catechol-O-methyltransferase activity in five large families
26. Genetics of red cell COMT activity: analysis of thermal stability and family data
27. Monoamine oxidase, brain aging and degenerative disease
28. Substrate specificity of type A and B monoamine oxidase
29. Human erythrocyte catechol-O-methyltransferase: Correlation with lung and kidney activity
30. Biochemical genetics of catecholamines in humans
31. Human pharmacogenetics of methyl conjugation
32. A sensitive and specific assay for the estimation of monoamine oxidase
33. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines
34. Assessment of catechol-O-methyltransferase activity and its inhibition in erythrocytes of animals and humans